Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

[Molecular breast imaging. An update].

Pinker K, Helbich TH, Magometschnigg H, Fueger B, Baltzer P.

Radiologe. 2014 Mar;54(3):241-53. doi: 10.1007/s00117-013-2580-8. German.

PMID:
24557495
2.

[Multiparametric and molecular imaging of breast tumors with MRI and PET/MRI].

Pinker K, Marino MA, Dr Meyer-Baese A, Helbich TH.

Radiologe. 2016 Jul;56(7):612-21. doi: 10.1007/s00117-016-0129-3. Review. German.

PMID:
27364727
3.

[Hemato-oncological imaging : Importance of hybrid procedures].

Mayerhoefer ME, Haug A.

Radiologe. 2016 Jul;56(7):597-604. doi: 10.1007/s00117-016-0126-6. Review. German.

PMID:
27335021
4.

Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.

Pinker K, Bogner W, Baltzer P, Gruber S, Bickel H, Brueck B, Trattnig S, Weber M, Dubsky P, Bago-Horvath Z, Bartsch R, Helbich TH.

Invest Radiol. 2014 Jun;49(6):421-30. doi: 10.1097/RLI.0000000000000029.

PMID:
24566292
5.

Molecular imaging for the characterization of breast tumors.

Magometschnigg HF, Helbich T, Brader P, Abeyakoon O, Baltzer P, Füger B, Wengert G, Polanec S, Bickel H, Pinker K.

Expert Rev Anticancer Ther. 2014 Jun;14(6):711-22. doi: 10.1586/14737140.2014.885383. Epub 2014 Feb 19. Review.

PMID:
24552125
6.

Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT.

An YY, Kim SH, Kang BJ, Lee AW.

J Korean Med Sci. 2015 Jun;30(6):808-15. doi: 10.3346/jkms.2015.30.6.808. Epub 2015 May 13. Erratum in: J Korean Med Sci. 2015 Dec;30(12):1924.

7.

Multiparametric MRI With Dynamic Contrast Enhancement, Diffusion-Weighted Imaging, and 31-Phosphorus Spectroscopy at 7 T for Characterization of Breast Cancer.

Schmitz AM, Veldhuis WB, Menke-Pluijmers MB, van der Kemp WJ, van der Velden TA, Kock MC, Westenend PJ, Klomp DW, Gilhuijs KG.

Invest Radiol. 2015 Nov;50(11):766-71. doi: 10.1097/RLI.0000000000000183.

PMID:
26135017
8.

The potential of multiparametric MRI of the breast.

Pinker K, Helbich TH, Morris EA.

Br J Radiol. 2017 Jan;90(1069):20160715. doi: 10.1259/bjr.20160715. Epub 2016 Nov 2. Review.

9.

[Clinical evaluation of female pelvic tumors : Application fields of integrated PET/MRI].

Grueneisen J, Umutlu L.

Radiologe. 2016 Jul;56(7):605-11. doi: 10.1007/s00117-016-0127-5. Review. German.

PMID:
27315240
10.

Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study.

Pinker K, Bogner W, Baltzer P, Karanikas G, Magometschnigg H, Brader P, Gruber S, Bickel H, Dubsky P, Bago-Horvath Z, Bartsch R, Weber M, Trattnig S, Helbich TH.

Clin Cancer Res. 2014 Jul 1;20(13):3540-9. doi: 10.1158/1078-0432.CCR-13-2810.

11.

[Molecular imaging of head and neck cancers : Perspectives of PET/MRI].

Stumpp P, Purz S, Sabri O, Kahn T.

Radiologe. 2016 Jul;56(7):588-96. doi: 10.1007/s00117-016-0125-7. Review. German.

PMID:
27306200
12.

Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors.

Aribal E, Asadov R, Ramazan A, Ugurlu MÜ, Kaya H.

Eur J Radiol. 2016 May;85(5):979-86. doi: 10.1016/j.ejrad.2016.02.022. Epub 2016 Feb 26.

PMID:
27130059
13.

Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.

Grueneisen J, Nagarajah J, Buchbender C, Hoffmann O, Schaarschmidt BM, Poeppel T, Forsting M, Quick HH, Umutlu L, Kinner S.

Invest Radiol. 2015 Aug;50(8):505-13. doi: 10.1097/RLI.0000000000000197.

PMID:
26115367
14.

[Functional and molecular imaging of breast tumors].

Pinker K, Brader P, Karanikas G, El-Rabadi K, Bogner W, Gruber S, Reisegger M, Trattnig S, Helbich TH.

Radiologe. 2010 Nov;50(11):1030-8. doi: 10.1007/s00117-010-2014-9. German.

PMID:
20842342
15.

Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.

Pace L, Nicolai E, Luongo A, Aiello M, Catalano OA, Soricelli A, Salvatore M.

Eur J Radiol. 2014 Feb;83(2):289-96. doi: 10.1016/j.ejrad.2013.11.002. Epub 2013 Nov 23.

PMID:
24331845
16.

Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?

Weber MA, Henze M, Tüttenberg J, Stieltjes B, Meissner M, Zimmer F, Burkholder I, Kroll A, Combs SE, Vogt-Schaden M, Giesel FL, Zoubaa S, Haberkorn U, Kauczor HU, Essig M.

Invest Radiol. 2010 Dec;45(12):755-68. doi: 10.1097/RLI.0b013e3181ec9db0.

PMID:
20829706
17.

Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.

Ergul N, Kadioglu H, Yildiz S, Yucel SB, Gucin Z, Erdogan EB, Aydin M, Muslumanoglu M.

Acta Radiol. 2015 Aug;56(8):917-23. doi: 10.1177/0284185114539786. Epub 2014 Jul 10.

PMID:
25013091
18.

Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer.

Eby PR, Partridge SC, White SW, Doot RK, Dunnwald LK, Schubert EK, Kurland BF, Lehman CD, Mankoff DA.

Acad Radiol. 2008 Oct;15(10):1246-54. doi: 10.1016/j.acra.2008.03.019.

19.

Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRI.

Yoon H, Yoon D, Yun M, Choi JS, Park VY, Kim EK, Jeong J, Koo JS, Yoon JH, Moon HJ, Kim S, Kim MJ.

PLoS One. 2016 Jul 26;11(7):e0159949. doi: 10.1371/journal.pone.0159949. eCollection 2016.

20.

Functional magnetic resonance: biomarkers of response in breast cancer.

O'Flynn EA, DeSouza NM.

Breast Cancer Res. 2011 Feb 23;13(1):204. doi: 10.1186/bcr2815. Review. Erratum in: Breast Cancer Res. 2011;13(3):405.

Supplemental Content

Support Center